BLOG
Tanning Injections — The Complete Guide to MT2 Dosage, Results, and Melanotan 2 Benefits in 2026
Few topics in the peptide research space generate as much curiosity — and as much misinformation — as tanning injections. If you have been searching for accurate information on MT2 dosage, trying to understand what realistic MT2 results look like, wondering whether to use melanotan before or after tanning, or exploring what the full range of melanotan 2 benefits actually includes beyond skin pigmentation — you have found the most comprehensive and evidence-grounded guide available.
This complete guide from Peptides Lab covers everything — from how melanotan 2 peptide works at the receptor level, to melanotan 2 peptide dosage by skin type, what tanning injections before and after results realistically look like week by week, what tanning drops under tongue are and how they compare to injections, and what the published research actually says about the full spectrum of melanotan 2 benefits.
What Are Tanning Injections and How Does Melanotan 2 Peptide Work in the Body?
Tanning injections refer to the subcutaneous or intramuscular administration of melanotan 2 peptide — a synthetic analog of the naturally occurring alpha-melanocyte stimulating hormone (α-MSH). Melanotan 2 (MT2) was originally developed at the University of Arizona as part of a research program investigating photoprotective compounds — the hypothesis being that artificially stimulating melanogenesis could protect fair-skinned individuals from UV-induced skin damage and reduce skin cancer risk.
MT2 works by binding to and activating melanocortin receptors — specifically MC1R, MC3R, MC4R, and MC5R — throughout the body. MC1R activation on melanocytes triggers the production and release of eumelanin — the dark brown-black pigment responsible for skin tanning. Unlike the tanning response triggered by UV exposure alone, melanotan 2 peptide stimulates melanin production systemically and continuously, regardless of UV exposure — though UV light significantly amplifies and accelerates the pigmentation response.
How melanotan 2 peptide stimulates melanocyte stimulating hormone receptors
The natural α-MSH peptide has a half-life of just minutes in circulation, limiting its ability to produce sustained melanogenesis. MT2’s structural modifications — including a cyclic structure and D-phenylalanine substitution — extend its half-life to approximately 36 hours, producing the prolonged receptor activation that drives the sustained tanning response observed in tanning injections before and after documentation. This extended activity is what makes MT2 results qualitatively different from the transient UV-induced tanning response.
MT2 Dosage Guide — How Much Melanotan 2 Should You Take for Safe and Effective Results?
MT2 dosage is the single most important variable in any tanning injections protocol — both for efficacy and for side effect management. The core principle of MT2 dosage is to start low and escalate slowly, giving the body time to adapt to melanocortin receptor activation before increasing the peptide load.
Standard MT2 dosage framework:
Loading phase (weeks 1–4): The loading phase establishes baseline melanin activation and determines individual sensitivity. Starting MT2 dosage recommendations are:
- Skin types I–II (very fair, burns easily, rarely tans): Begin at 100mcg per administration
- Skin types III–IV (medium, tans moderately): Begin at 250mcg per administration
- Skin types V–VI (olive to dark, tans easily): Begin at 250–500mcg per administration
Administer once daily in the evening — nausea is the most common initial side effect and is significantly reduced by evening administration before sleep.
Escalation protocol: Increase MT2 dosage by 100–250mcg every 5–7 days as tolerated until reaching a maintenance dose of 500mcg–1mg per administration. Most users find their optimal melanotan 2 peptide dosage in the 500–750mcg range.
Maintenance phase (ongoing): Once desired pigmentation is achieved, MT2 dosage can be dramatically reduced. Most users maintain results with 500mcg once every 3–7 days — depending on UV exposure frequency and individual melanin response.
How to calculate your correct melanotan 2 peptide dosage based on body weight
Research protocols have used weight-based melanotan 2 peptide dosage calculations of approximately 0.025mg per kg of body weight as a starting reference. For a 70kg individual this equates to approximately 1.75mg total weekly in divided doses — consistent with the standard loading protocol above. Individual sensitivity varies considerably however and weight-based calculation should serve as a starting reference rather than a fixed prescription.
Melanotan 2 Peptide Dosage — Beginner, Intermediate, and Maintenance Protocols Explained
Here is a comprehensive melanotan 2 peptide dosage reference across protocol phases and skin types:
| Phase | Skin Type I–II | Skin Type III–IV | Skin Type V–VI | Frequency |
|---|---|---|---|---|
| Loading week 1 | 100mcg | 250mcg | 250mcg | Daily |
| Loading week 2 | 250mcg | 500mcg | 500mcg | Daily |
| Loading week 3–4 | 500mcg | 750mcg | 750mcg–1mg | Daily |
| Maintenance | 250–500mcg | 500mcg | 500mcg | Every 3–7 days |
| UV session boost | 250mcg | 500mcg | 500mcg | Before UV only |
MT2 dosage for skin type I and II — the highest sensitivity protocol
Skin types I and II — characterized by very fair complexion, blue or green eyes, red or blonde hair, and a strong tendency to burn with minimal tanning — are the highest sensitivity group for MT2 dosage. Starting at 100mcg rather than the standard 250mcg is essential for this group to minimize nausea, flushing, and facial flushing that are most pronounced in individuals with the highest MC1R expression. The tradeoff is that skin types I and II also tend to experience the most dramatic MT2 results — producing visible pigmentation that would otherwise be virtually impossible for them to achieve through UV exposure alone.
What Are Tanning Drops Under Tongue — How Do They Compare to Tanning Injections?
One of the most common questions asked alongside MT2 dosage and tanning injections is: what are tanning drops under tongue and are they a viable alternative to injection-based protocols?
Tanning drops under tongue — also marketed as sublingual melanotan drops — are liquid formulations of melanotan peptide designed for absorption through the sublingual mucosa (the tissue beneath the tongue). The rationale is that sublingual absorption bypasses first-pass hepatic metabolism and delivers the peptide directly into venous circulation.
What are tanning drops under tongue and why bioavailability matters for MT2 results
The honest assessment of tanning drops under tongue vs. tanning injections comes down to one fundamental factor — bioavailability. Subcutaneous injection of melanotan 2 peptide delivers approximately 90–100% of the administered dose into systemic circulation. Sublingual peptide absorption is significantly more variable and generally lower — typically in the range of 20–40% for most peptide molecules, depending on molecular weight, formulation pH, and mucosal contact time.
The practical implication is that tanning drops under tongue require significantly higher doses to achieve equivalent MT2 results compared to tanning injections — and the consistency of absorption is considerably less predictable. For researchers seeking reproducible, dose-controlled MT2 results, subcutaneous injection remains the gold-standard delivery method.
That said, tanning drops under tongue represent a lower barrier option for individuals who cannot or will not self-inject, and some users report satisfactory pigmentation results with sublingual administration — particularly at higher doses and with consistent UV exposure.
| Factor | Tanning Injections | Tanning Drops Under Tongue |
|---|---|---|
| Bioavailability | 90–100% | 20–40% (variable) |
| Onset time | 15–30 minutes | 30–60 minutes |
| Dose consistency | High | Low to moderate |
| Convenience | Moderate | High |
| Cost per equivalent dose | Lower | Higher |
| MT2 results quality | Superior | Good at higher doses |
Tanning Injections Before and After — What Real MT2 Results Look Like Over Time
Tanning injections before and after documentation is one of the most searched aspects of melanotan 2 peptideresearch — and for good reason. Understanding what realistic MT2 results look like across different skin types and timeframes is essential for setting appropriate expectations.
MT2 results — what to expect week by week:
Week 1–2: Early MT2 results are typically subtle. Most users report a mild deepening of existing tan, increased freckling in sun-exposed areas (particularly in skin types I–II), and improved tanning response during UV sessions. Nausea is most commonly reported during this phase — typically resolving within the first 7–10 days as receptor adaptation occurs.
Week 3–4: Visible pigmentation changes become apparent for most skin types during this window. Skin tone deepens noticeably, freckling integrates into a more uniform tan, and the contrast between sun-exposed and unexposed areas begins to equalize. Tanning injections before and after photos from this phase typically show the most dramatic early transformation.
Week 5–8: The primary MT2 results phase. Pigmentation reaches its peak depth for the given MT2 dosage protocol, UV responsiveness is maximized, and maintenance dosing can begin for users satisfied with their achieved tone. Skin type I–II users often achieve pigmentation levels resembling natural skin types III–IV during this phase.
Week 9–12 and beyond: Maintenance phase. With reduced MT2 dosage and regular UV exposure, pigmentation achieved in the loading phase is sustained with minimal additional peptide. Tanning injections before and afterdocumentation at this stage shows stable, even pigmentation that far exceeds what UV exposure alone could produce.
Melanotan Before or After Tanning — Timing Your Protocol for Maximum Pigmentation
The question of whether to use melanotan before or after tanning is one of the most practically important timing decisions in any tanning injections protocol.
Melanotan before or after tanning — the science behind UV activation timing
The consensus from available research is clear — melanotan before tanning produces significantly better MT2 resultsthan post-UV administration. The mechanism is straightforward: melanotan 2 peptide activates melanocytes and stimulates melanin synthesis in the hours following administration. When UV exposure occurs during this window of peak melanocyte activation, the synergistic effect on eumelanin production is substantially greater than either stimulus alone.
Recommended timing:
- Administer MT2 dosage 60–90 minutes before planned UV exposure for maximum synergistic pigmentation response
- Minimum UV session duration: 10–15 minutes for skin types I–II during loading phase, increasing gradually
- Always use broad-spectrum SPF 15–30 during early loading phase to prevent burning — melanotan 2 peptide does not provide immediate photoprotection
What happens if you use melanotan after tanning: Post-UV administration still contributes to melanin synthesis but misses the window of peak UV-melanocyte synergy. Over time the cumulative effect is similar but the rate of visible MT2 results is meaningfully slower. For time-sensitive protocols, pre-UV administration is always preferred.
Melanotan 2 Benefits — Beyond Tanning, What Else Does MT2 Actually Do?
The melanotan 2 benefits profile extends considerably beyond skin pigmentation — and understanding the full receptor pharmacology of MT2 explains why.
Melanotan 2 benefits — the complete receptor profile:
MC1R activation — skin pigmentation and photoprotection: The primary melanotan 2 benefits mechanism for tanning. Published research suggests that melanin stimulated by MT2 may provide some degree of photoprotective activity — absorbing UV radiation before it reaches DNA in basal layer keratinocytes. This potential photoprotective benefit was the original scientific rationale for the University of Arizona research program.
MC3R and MC4R activation — appetite suppression and metabolic effects: MC3R and MC4R are expressed in the hypothalamus and play key roles in energy homeostasis. Melanotan 2 benefits through these receptors include significant appetite suppression — consistently reported by users and documented in published research — and potential metabolic rate elevation through hypothalamic signaling pathways. These effects make MT2 of particular research interest in the obesity and metabolic syndrome research community.
MC4R activation — erectile function and libido: One of the most widely reported melanotan 2 benefits in published human clinical research is improved erectile function and libido in both men and women. The MC4R pathway in the central nervous system plays a well-documented role in sexual arousal and function. Published clinical trials on PT-141 (bremelanotide) — a closely related melanocortin peptide — have demonstrated this mechanism sufficiently for FDA approval of the compound for hypoactive sexual desire disorder in women. MT2’s activity at the same receptor explains the libido-enhancing effect consistently reported in user documentation and early clinical research.
MC5R activation — exocrine gland regulation: MC5R activation by melanotan 2 peptide influences sebaceous gland function and various exocrine secretions. The clinical significance of this receptor activation in the context of tanning injections protocols is modest but contributes to the occasionally reported side effect of facial flushing and increased oiliness in some users.
Melanotan 2 benefits for photoprotection — does MT2 actually protect skin from UV damage?
The photoprotective potential of melanotan 2 benefits is one of the most scientifically interesting aspects of MT2 research. Melanin produced in response to tanning injections is structurally and functionally equivalent to UV-induced melanin and provides comparable UV absorption characteristics. However it is critical to note that the level of photoprotection provided — even with substantial MT2-induced pigmentation — is modest and should never be used as a substitute for conventional sun protection. SPF application remains essential regardless of MT2 results.
Tanning Injections Side Effects — What You Need to Know Before Starting MT2
Honest disclosure of tanning injections side effects is non-negotiable. Here is a comprehensive breakdown:
Common side effects (reported in majority of users):
- Nausea — the most universally reported side effect, typically during the first 1–2 weeks at higher MT2 dosage. Minimized by evening administration and starting at low doses
- Facial flushing — transient redness and warmth in the face and neck, particularly in the 30–60 minutes following administration. Generally resolves within 1–2 hours
- Spontaneous erections in men — a direct consequence of MC4R activation. Reported as an unwanted side effect by some and a welcomed benefit by others
- Yawning and fatigue — commonly reported during the first few weeks. Generally transient
Less common side effects:
- Increased freckling and mole darkening — new or existing melanocytic lesions may darken in response to systemic melanocyte activation. Any new, asymmetric, or rapidly changing lesion should be evaluated by a dermatologist
- Appetite suppression — a significant reduction in appetite is commonly reported, particularly at higher melanotan 2 peptide dosage. May be beneficial or problematic depending on individual goals
- Mild headache — reported in some users at higher doses, typically resolving with dose reduction
Important safety considerations:
- Regular skin checks by a qualified dermatologist are strongly recommended for anyone using tanning injections
- MT2 is not recommended for individuals with a personal or family history of melanoma or other skin cancers
- Melanotan 2 peptide is not FDA approved and is available for research purposes only
How to Reconstitute and Administer Tanning Injections Safely and Correctly
Proper reconstitution and administration technique is essential for both safety and consistent MT2 results.
Reconstitution protocol:
- Add 1–2ml of bacteriostatic water to a lyophilized MT2 vial using a sterile insulin syringe
- Inject the water slowly along the inner wall of the vial — never directly onto the powder
- Gently swirl — never shake — until fully dissolved
- For a 10mg vial reconstituted with 2ml bacteriostatic water: each 0.1ml (10 units on an insulin syringe) = 500mcg MT2
Storage:
- Lyophilized (unreconstituted): store at -20°C, stable for 24+ months
- Reconstituted solution: store at 2–8°C, use within 30 days
- Protect from light at all times
Administration technique:
- Use 29–31 gauge insulin syringes for subcutaneous administration
- Clean injection site with alcohol swab
- Pinch skin and insert needle at 45° angle into subcutaneous fat — abdomen, outer thigh, or upper arm
- Rotate injection sites with each administration
- Administer in the evening 60–90 minutes before planned UV exposure or before sleep
MT2 Dosage for Different Skin Types — The Fitzpatrick Scale Explained
The Fitzpatrick scale is the standard dermatological classification for skin type — and it is the most useful framework for personalizing MT2 dosage:
| Fitzpatrick Type | Description | Starting MT2 Dosage | Expected MT2 Results |
|---|---|---|---|
| Type I | Always burns, never tans, very fair | 100mcg | Dramatic — significant achievable tan |
| Type II | Usually burns, tans minimally | 100–250mcg | Strong — considerable darkening |
| Type III | Sometimes burns, tans gradually | 250mcg | Good — accelerated natural tan |
| Type IV | Rarely burns, tans easily | 250–500mcg | Moderate — deepens existing tone |
| Type V | Brown skin, minimal burn risk | 500mcg | Subtle — modest deepening |
| Type VI | Dark brown/black, never burns | 500mcg–1mg | Minimal — limited additional pigmentation |
Frequently Asked Questions
What are tanning injections and how does melanotan 2 peptide work?
Tanning injections involve the subcutaneous administration of melanotan 2 peptide — a synthetic α-MSH analog that activates melanocortin receptors on melanocytes to stimulate eumelanin production. Unlike UV-induced tanning, MT2 drives melanin synthesis systemically and continuously, producing deeper and more even pigmentation than UV exposure alone can achieve.
What is the correct MT2 dosage for a first-time user?
For first-time users, the correct MT2 dosage depends on skin type. Skin types I–II should begin at 100mcg per administration, while skin types III–IV can begin at 250mcg. Administer in the evening to minimize nausea and escalate slowly by 100–250mcg every 5–7 days as tolerated toward a maintenance dose of 500mcg–1mg.
What are tanning drops under tongue and are they as effective as injections?
Tanning drops under tongue are sublingual liquid formulations of melanotan peptide. While more convenient than injections, their bioavailability is significantly lower — approximately 20–40% compared to 90–100% for subcutaneous injection. Tanning drops under tongue can produce MT2 results at higher doses but offer less predictable absorption and require larger amounts of peptide per equivalent effect.
Should I use melanotan before or after tanning?
Use melanotan before tanning — specifically 60–90 minutes before UV exposure — for maximum MT2 results. Pre-UV administration synchronizes peak melanocyte activation with UV stimulus, producing a synergistic eumelanin response significantly greater than either alone. Post-UV administration still works but produces results more slowly.
What are the main melanotan 2 benefits beyond skin tanning?
Melanotan 2 benefits beyond tanning include appetite suppression through MC3R/MC4R hypothalamic activation, improved erectile function and libido through MC4R pathway activity, potential modest photoprotection from elevated eumelanin levels, and metabolic rate effects. These additional melanotan 2 benefits are directly linked to the multi-receptor pharmacology of MT2.
How long does it take to see MT2 results?
Initial MT2 results — mild deepening of tan and increased UV responsiveness — are typically visible within the first 1–2 weeks. Significant visible pigmentation changes for most skin types emerge during weeks 3–4. Peak MT2 results are generally achieved between weeks 6–8 on a standard loading protocol with regular UV exposure.
Are tanning injections safe and what should I know before starting?
Tanning injections carry a side effect profile dominated by nausea, flushing, and spontaneous erections — most of which are transient and dose-dependent. More serious considerations include the need for regular dermatological skin checks during use, the contraindication for individuals with personal or family history of melanoma, and the research-only regulatory status of melanotan 2 peptide in most jurisdictions. Always source from a verified supplier with independent third-party COA documentation.
Final Thoughts: Tanning Injections — Research, Responsibility, and Results
Tanning injections occupy a unique space in the peptide research landscape — simultaneously one of the most widely used and most misunderstood compounds in the category. The science behind melanotan 2 peptide is genuine, the melanotan 2 benefits are multifaceted, and when approached with the right MT2 dosage protocol and appropriate safety awareness — the MT2 results speak for themselves in tanning injections before and after documentation worldwide.
Whether you are beginning your first melanotan 2 peptide dosage protocol, exploring tanning drops under tongue as an alternative, trying to optimize your melanotan before or after tanning timing, or simply educating yourself on the full range of melanotan 2 benefits — Peptides Lab is your most trusted source for verified, third-party tested MT2 and the accurate information to use it responsibly.
Browse our complete tanning injections range, review our published batch COAs, and start your MT2 protocol with complete confidence — only at Peptides Lab.
References
- Hadley, M.E. & Dorr, R.T. (2006). Melanocortin peptide therapeutics — historical milestones, clinical studies and commercialization. Peptides, 27(4), 921–930.
- Dorr, R.T., et al. (1996). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 58(20), 1777–1784.
- Wessells, H., et al. (1998). Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology, 52(6), 1007–1012.
- Bremelanotide (PT-141) FDA Approval Documentation. (2019). Vyleesi — FDA prescribing information. US Food and Drug Administration. www.fda.gov
- Mountjoy, K.G. (2010). Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochemical Journal, 428(3), 305–324.
- Wikberg, J.E. (1999). Melanocortin receptors — perspectives for novel drugs. European Journal of Pharmacology, 375(1–3), 295–310.
- Fitzgerald, L.M., et al. (2008). Melanocortin 1 receptor (MC1R) gene sequence variation and melanoma risk. Human Mutation, 29(8), 1078–1086.
- Bohm, M., et al. (2005). Evidence for a melanocortin receptor-1 and 5 independent pathway for the regulation of melanogenesis. Experimental Dermatology, 14(12), 891–899.
- Cone, R.D. (2005). Anatomy and regulation of the central melanocortin system. Nature Neuroscience, 8(5), 571–578.
- World Anti-Doping Agency. (2024). Prohibited List — Peptide Hormones and Related Substances. WADA. www.wada-ama.org
